heltzen press release investor press clippings eXoZymes highlights scalable biomanufacturing platform and first spinout, NCTx, on Grow Everything podcast May 16, 2025 9:09:00 AM
press release investor eXoZymes provides first quarter 2025 and NCTx subsidiary update at 5PM EST today May 12, 2025 4:04:00 PM
press release investor eXoZymes to host first quarter 2025 and subsidiary NCTx update on Monday May 12, 2025, at 5PM EST May 7, 2025 4:58:15 PM
press release investor nutraceuticals medicine science eXoZymes launches subsidiary, NCTx, to unlock a promising compound for gut and liver health May 6, 2025 4:09:00 PM
press release investor video science GEN Biotechnology cover story: Bringing clarity and precision to the cell-free space by introducing exozymes Apr 21, 2025 4:10:00 PM
press release investor science BioClick – an enzyme engineering game-changer, launched by eXoZymes and supported by a $300K NIH grant Apr 10, 2025 4:14:15 PM
talent press release investor video eXoZymes appoints experienced biomanufacturing executive, Damien Perriman, as CCO Apr 2, 2025 4:10:00 PM
press release investor eXoZymes Provides Fourth Quarter and Full Year 2024 Update Apr 2, 2025 4:05:00 PM
press release IPO investor eXoZymes to Host Fourth Quarter and Full Year 2024 Results Conference Call on Wednesday April 2, 2025 Mar 26, 2025 4:46:17 PM
press release investor eXoZymes and MDB Capital Announce Leadership Transition at eXoZymes Inc. Feb 21, 2025 4:05:00 PM
